Saponins from chinese medicines as anticancer agents

Molecules

Volumn 21, Issue 10, 2016, Pages

  Xu, Xiao Huang ^a   Li, Ting ^a   Fong, Chi Man Vivienne ^a   Chen, Xiuping ^a   Chen, Xiao Jia ^a   Wang, Yi Tao ^a   Huang, Ming Qing ^b   Lu, Jin Jian ^a  

^a University of Macau   (Macao)

^b FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cancer; Mechanism; Steroid Saponins; Target; Triterpenoid Saponins

Indexed keywords

ANTINEOPLASTIC AGENT; SAPONIN;

ANIMAL; CHEMISTRY; CHINESE MEDICINE; DRUG EFFECTS; DRUG RESISTANCE; HUMAN; MEDICINAL PLANT; METABOLISM; NEOPLASMS; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG RESISTANCE, NEOPLASM; HUMANS; MEDICINE, CHINESE TRADITIONAL; NEOPLASMS; PLANTS, MEDICINAL; SAPONINS; SIGNAL TRANSDUCTION;

EID: 84992336060     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21101326     Document Type: Review

References (218)

1. Lu, J.J.; Dang, Y.Y.; Huang, M.; Xu, W.S.; Chen, X.P.; Wang, Y.T. Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae-A review. J. Ethnopharmacol. 2012, 143, 406-411.
2. Lu, J.J.; Bao, J.L.; Wu, G.S.; Xu, W.S.; Huang, M.Q.; Chen, X.P.; Wang, Y.T. Quinones derived from plant secondary metabolites as anti-cancer agents. Anti-Cancer Agents Med. Chem. 2013, 13, 456-463.
3. Lu, J.J.; Bao, J.L.; Chen, X.P.; Huang, M.;Wang, Y.T. Alkaloids isolated from natural herbs as the anticancer agents. Evid.-Based Complement. Altern. Med. 2012, 2012, 485042.
4. Zheng, M.; Zhao, M.; Tang, L.; Zhang, C.; Song, L.; Wang, W. Ginsenoside Rg1 attenuates hypoxia and hypercapnia-induced vasoconstriction in isolated rat pulmonary arterial rings by reducing the expression of p38. J. Thorac. Dis. 2016, 8, 1513-1523.
5. Xiang, L.; Yi, X.; Wang, Y.; He, X. Antiproliferative and anti-inflammatory polyhydroxylated spirostanol saponins from Tupistra chinensis. Sci. Rep. 2016, 6.
6. Song, G.; Shen, X.; Li, S.; Li, Y.; Si, H.; Fan, J.; Li, J.; Gao, E.; Liu, S. Structure-Activity relationships of 3-O-chacotriosyl oleanane-Type triterpenoids as potential H5N1 entry inhibitors. Eur. J. Med. Chem. 2016, 119, 109-121.
7. Khan, M.; Maryam, A.; Zhang, H.; Mehmood, T.; Ma, T. Killing cancer with platycodin D through multiple mechanisms. J. Cell. Mol. Med. 2016, 20, 389-402.
8. Chen, M.F.; Huang, S.J.; Huang, C.C.; Liu, P.S.; Lin, K.I.; Liu, C.W.; Hsieh, W.C.; Shiu, L.Y.; Chen, C.H. Saikosaponin D induces cell death through caspase-3-dependent, caspase-3-independent and mitochondrial pathways in mammalian hepatic stellate cells. BMC Cancer 2016, 16.
9. Cheng, G.; Gao, F.; Sun, X.; Bi, H.; Zhu, Y. Paris saponin vii suppresses osteosarcoma cell migration and invasion by inhibiting MMP-2/9 production via the p38 mapk signaling pathway. Mol. Med. Rep. 2016.
10. Zeng, K.W.; Song, F.J.; Li, N.; Dong, X.; Jiang, Y.; Tu, P.F. ASC, a bioactive steroidal saponin from Ophitopogin japonicas, inhibits angiogenesis through interruption of SRC tyrosine kinase-dependent matrix metalloproteinase pathway. Basic Clin. Pharmacol. Toxicol. 2015, 116, 115-123.
11. Zhu, X.; Jiang, H.; Li, J.; Xu, J.; Fei, Z. Anticancer effects of paris saponins by apoptosis and PI3k/AKT pathway in gefitinib-resistant non-small cell lung cancer. Med. Sci. Monit. 2016, 22, 1435-1441.
12. Zhao, P.J.; Song, S.C.; Du, L.W.; Zhou, G.H.; Ma, S.L.; Li, J.H.; Feng, J.G.; Zhu, X.H.; Jiang, H. Paris saponins enhance radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line by inducing apoptosis and G2/M cell cycle phase arrest. Mol. Med. Rep. 2016, 13, 2878-2884.
13. Chu, S.F.; Zhang, J.T. New achievements in ginseng research and its future prospects. Chin. J. Integr. Med. 2009, 15, 403-408.
14. Wang, C.Z.; Anderson, S.; Du, W.; He, T.C.; Yuan, C.S. Red ginseng and cancer treatment. Chin. J. Natl. Med. 2016, 14, 7-16.
15. Wang, X.Y.; Wang, Y.G.; Wang, Y.F. Ginsenoside Rb1, Rg1 and three extracts of traditional chinese medicine attenuate ultraviolet B-induced G1 growth arrest in hacat cells and dermal fibroblasts involve down-regulating the expression of p16, p21 and p53. Photodermatol. Photoimmunol. Photomed. 2011, 27, 203-212.
16. Fujimoto, J.; Sakaguchi, H.; Aoki, I.; Toyoki, H.; Khatun, S.; Tamaya, T. Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane. Eur. J. Gynaecol. Oncol. 2001, 22, 339-341.
17. Lee, Y.J.; Jin, Y.R.; Lim, W.C.; Ji, S.M.; Cho, J.Y.; Ban, J.J.; Lee, S.K. Ginsenoside Rc and Re stimulate c-fos expression in MCF-7 human breast carcinoma cells. Arch. Pharm. Res. 2003, 26, 53-57.
18. Kim, B.J. Involvement of melastatin type transient receptor potential 7 channels in ginsenoside Rd-induced apoptosis in gastric and breast cancer cells. J. Ginseng Res. 2013, 37, 201-209.
19. Kim, J.S.; Joo, E.J.; Chun, J.; Ha, Y.W.; Lee, J.H.; Han, Y.; Kim, Y.S. Induction of apoptosis by ginsenoside Rk1 in SK-MEL-2-human melanoma. Arch. Pharm. Res. 2012, 35, 717-722.
20. Jang, H.J.; Han, I.H.; Kim, Y.J.; Yamabe, N.; Lee, D.; Hwang, G.S.; Oh, M.; Choi, K.C.; Kim, S.N.; Ham, J.; et al. Anticarcinogenic effects of products of heat-processed ginsenoside Re, a major constituent of ginseng berry, on human gastric cancer cells. J. Agric. Food Chem. 2014, 62, 2830-2836.
21. Ahn, S.; Siddiqi, M.H.; Aceituno, V.C.; Simu, S.Y.; Yang, D.C. Suppression of MAPKs/NF-B activation induces intestinal anti-inflammatory action of ginsenoside Rf in Ht-29 and raw264.7 cells. Immunol. Investig. 2016.
22. Qiu, X.M.; Bai, X.; Jiang, H.F.; He, P.; Wang, J.H. 20-(S)-ginsenoside Rg3 induces apoptotic cell death in human leukemic U937 and HL-60 cells through PI3K/AKT pathways. Anti-Cancer Drugs 2014, 25, 1072-1080.
23. Park, D.; Bae, D.K.; Jeon, J.H.; Lee, J.; Oh, N.; Yang, G.; Yang, Y.H.; Kim, T.K.; Song, J.; Lee, S.H.; et al. Immunopotentiation and antitumor effects of a ginsenoside Rg3-fortified red ginseng preparation in mice bearing H460 lung cancer cells. Environ. Toxicol. Pharmacol. 2011, 31, 397-405.
24. Chang, L.; Huo, B.; Lv, Y.;Wang, Y.; Liu, W. Ginsenoside Rg3 enhances the inhibitory effects of chemotherapy on esophageal squamous cell carcinoma in mice. Mol. Clin. Oncol. 2014, 2, 1043-1046.
25. Park, E.H.; Kim, Y.J.; Yamabe, N.; Park, S.H.; Kim, H.K.; Jang, H.J.; Kim, J.H.; Cheon, G.J.; Ham, J.; Kang, K.S. Stereospecific anticancer effects of ginsenoside Rg3 epimers isolated from heat-processed american ginseng on human gastric cancer cell. J. Ginseng Res. 2014, 38, 22-27.
26. Kim, S.M.; Lee, S.Y.; Yuk, D.Y.; Moon, D.C.; Choi, S.S.; Kim, Y.; Han, S.B.; Oh, K.W.; Hong, J.T. Inhibition of NF-B by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch. Pharm. Res. 2009, 32, 755-765.
27. He, B.C.; Gao, J.L.; Luo, X.; Luo, J.; Shen, J.;Wang, L.; Zhou, Q.;Wang, Y.T.; Luu, H.H.; Haydon, R.C.; et al. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of WNT/SS-catenin signaling. Int. J. Oncol. 2011, 38, 437-445.
28. Lee, S.Y.; Kim, G.T.; Roh, S.H.; Song, J.S.; Kim, H.J.; Hong, S.S.; Kwon, S.W.; Park, J.H. Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines. Biosci. Biotechnol. Biochem. 2009, 73, 811-816.
29. Jiang, J.W.; Chen, X.M.; Chen, X.H.; Zheng, S.S. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J. Gastroenterol. 2011, 17, 3605-3613.
30. Cheong, J.H.; Kim, H.; Hong, M.J.; Yang, M.H.; Kim, J.W.; Yoo, H.; Yang, H.; Park, J.H.; Sung, S.H.; Kim, H.P.; et al. Stereoisomer-specific anticancer activities of ginsenoside Rg3 and RH2 in HepG2 cells: Disparity in cytotoxicity and autophagy-inducing effects due to 20(S)-epimers. Biol. Pharma. Bull. 2015, 38, 102-108.
31. Chen, Q.J.; Zhang, M.Z.; Wang, L.X. Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells. Cell. Physiol. Biochem. 2010, 26, 849-858.
32. Lee, Y.J.; Lee, S.; Ho, J.N.; Byun, S.S.; Hong, S.K.; Lee, S.E.; Lee, E. Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatinresistant bladder tumor cell line. Oncol. Rep. 2014, 32, 1803-1808.
33. Kim, B.M.; Kim, D.H.; Park, J.H.; Na, H.K.; Surh, Y.J. Ginsenoside Rg3 induces apoptosis of human breast cancer (MDA-MB-231) cells. J. Cancer Prev. 2013, 18, 177-185.
34. Liu, T.; Zhao, L.; Zhang, Y.; Chen, W.; Liu, D.; Hou, H.; Ding, L.; Li, X. Ginsenoside 20(S)-Rg3 targets HIF-1-to block hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells. PLoS ONE 2014, 9, e103887.
35. Kim, S.M.; Lee, S.Y.; Cho, J.S.; Son, S.M.; Choi, S.S.; Yun, Y.P.; Yoo, H.S.; Yoon do, Y.; Oh, K.W.; Han, S.B.; et al. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-B. Eur. J. Pharmacol. 2010, 631.
36. Kim, H.S.; Lee, E.H.; Ko, S.R.; Choi, K.J.; Park, J.H.; Im, D.S. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch. Pharm. Res. 2004, 27, 429-435.
37. Shan, X.; Tian, L.L.; Zhang, Y.M.;Wang, X.Q.; Yan, Q.; Liu, J.W. Ginsenoside Rg3 suppresses FUT4 expression through inhibiting NF-B/p65 signaling pathway to promote melanoma cell death. Int. J. Oncol. 2015, 47, 701-709.
38. Chen, J.; Peng, H.; Ou-Yang, X.; He, X. Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells. Melanoma Res. 2008, 18, 322-329.
39. Shan, X.; Fu, Y.S.; Aziz, F.;Wang, X.Q.; Yan, Q.; Liu, J.W. Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation. PLoS ONE 2014, 9, e115401.
40. Zhang, Q.; Kang, X.; Zhao, W. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on lewis lung carcinoma. Biochem. Biophys. Res. Commun. 2006, 342, 824-828.
41. Xu, T.M.; Xin, Y.; Cui, M.H.; Jiang, X.; Gu, L.P. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. Chin. Med. J. 2007, 120, 584-588.
42. Zhang, Q.H.; Wu, C.F.; Duan, L.; Yang, J.Y. Protective effects of ginsenoside Rg3 against cyclophosphamide-induced DNA damage and cell apoptosis in mice. Arch. Toxicol. 2008, 82, 117-123.
43. Zhang, Q.; Kang, X.; Yang, B.; Wang, J.; Yang, F. Antiangiogenic effect of capecitabine combined with ginsenoside Rg3 on breast cancer in mice. Cancer Biother. Radiopharm. 2008, 23, 647-653.
44. Liu, T.G.; Huang, Y.; Cui, D.D.; Huang, X.B.; Mao, S.H.; Ji, L.L.; Song, H.B.; Yi, C. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer 2009, 9.
45. Lee, C.K.; Park, K.K.; Chung, A.S.; Chung, W.Y. Ginsenoside Rg3 enhances the chemosensitivity of tumors to cisplatin by reducing the basal level of nuclear factor erythroid 2-related factor 2-mediated heme oxygenase-1/NAD(P)H quinone oxidoreductase-1 and prevents normal tissue damage by scavenging cisplatin-induced intracellular reactive oxygen species. Food Chem. Toxicol. 2012, 50, 2565-2574.
46. Kim, D.G.; Jung, K.H.; Lee, D.G.; Yoon, J.H.; Choi, K.S.; Kwon, S.W.; Shen, H.M.; Morgan, M.J.; Hong, S.S.; Kim, Y.S. 20(S)-ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin. Oncotarget 2014, 5, 4438-4451.
47. Kim, S.S.; Seong, S.; Kim, S.Y. Synergistic effect of ginsenoside Rg3 with verapamil on the modulation of multidrug resistance in human acute myeloid leukemia cells. Oncol. Lett. 2014, 7, 1265-1269.
48. Lee, J.Y.; Jung, K.H.; Morgan, M.J.; Kang, Y.R.; Lee, H.S.; Koo, G.B.; Hong, S.S.; Kwon, S.W.; Kim, Y.S. Sensitization of trail-induced cell death by 20(S)-ginsenoside Rg3 via chop-mediated DR5 upregulation in human hepatocellular carcinoma cells. Mol. Cancer Ther. 2013, 12, 274-285.
49. Wang, L.; Li, X.; Song, Y.M.; Wang, B.; Zhang, F.R.; Yang, R.; Wang, H.Q.; Zhang, G.J. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to-radiation by targeting the nuclear factor-kappab pathway. Mol. Med. Rep. 2015, 12, 609-614.
50. Zeng, D.; Wang, J.; Kong, P.; Chang, C.; Li, J.; Li, J. Ginsenoside Rg3 inhibits HIF-1 and vegf expression in patient with acute leukemia via inhibiting the activation of PI3K/AKT and ERK1/2 pathways. Int. J. Clin. Exp. Pathol. 2014, 7, 2172-2178.
51. Wu, R.; Ru, Q.; Chen, L.; Ma, B.; Li, C. Stereospecificity of ginsenoside Rg3 in the promotion of cellular immunity in hepatoma H22-bearing mice. J. Food Sci. 2014, 79, H1430-H1435.
52. Joo, E.J.; Chun, J.; Ha, Y.W.; Ko, H.J.; Xu, M.Y.; Kim, Y.S. Novel roles of ginsenoside Rg3 in apoptosis through downregulation of epidermal growth factor receptor. Chem. Biol. Interact. 2015, 233, 25-34.
53. Shan, X.; Aziz, F.; Tian, L.L.; Wang, X.Q.; Yan, Q.; Liu, J.W. Ginsenoside Rg3-induced EGFR/MAPK pathway deactivation inhibits melanoma cell proliferation by decreasing FUT4/ley expression. Int. J. Oncol. 2015, 46, 1667-1676.
54. Kim, B.M.; Kim, D.H.; Park, J.H.; Surh, Y.J.; Na, H.K. Ginsenoside Rg3 inhibits constitutive activation of NF-B signaling in human breast cancer (MDA-MB-231) cells: ERK and AKT as potential upstream targets. J. Cancer Prev. 2014, 19, 23-30.
55. Chen, X.P.; Qian, L.L.; Jiang, H.; Chen, J.H. Ginsenoside Rg3 inhibits CXCR4 expression and related migrations in a breast cancer cell line. Int. J. Clin. Oncol. 2011, 16, 519-523.
56. Pan, X.Y.; Guo, H.; Han, J.; Hao, F.; An, Y.; Xu, Y.; Xiaokaiti, Y.; Pan, Y.; Li, X.J. Ginsenoside Rg3 attenuates cell migration via inhibition of aquaporin 1 expression in PC-3M prostate cancer cells. Eur. J. Pharmacol. 2012, 683, 27-34.
57. Wang, J.H.; Nao, J.F.; Zhang, M.; He, P. 20(S)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/AKT and XIAP pathways. Tumour Biol. 2014, 35, 11985-11994.
58. Kim, Y.J.; Choi, W.I.; Jeon, B.N.; Choi, K.C.; Kim, K.; Kim, T.J.; Ham, J.; Jang, H.J.; Kang, K.S.; Ko, H. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Toxicology 2014, 322, 23-33.
59. Li, J.; Liu, T.; Zhao, L.; Chen, W.; Hou, H.; Ye, Z.; Li, X. Ginsenoside 20(S) Rg3 inhibits the warburg effect through STAT3 pathways in ovarian cancer cells. Int. J. Oncol. 2015, 46, 775-781.
60. Luo, Y.; Zhang, P.; Zeng, H.Q.; Lou, S.F.; Wang, D.X. Ginsenoside Rg3 induces apoptosis in human multiple myeloma cells via the activation of Bcl-2-Associated x protein. Mol. Med. Rep. 2015, 12, 3557-3562.
61. Park, J.Y.; Choi, P.; Lee, D.; Kim, T.; Jung, E.B.; Hwang, B.S.; Kang, K.S.; Ham, J. Effect of amino acids on the generation of ginsenoside Rg3 epimers by heat processing and the anticancer activities of epimers in A2780 human ovarian cancer cells. Evid. Based Complement. Altern. Med. 2016, 2016.
62. Aziz, F.; Wang, X.; Liu, J.; Yan, Q. Ginsenoside Rg3 induces FUT4-mediated apoptosis in h. Pylori CAGA-Treated gastric cancer cells by regulating SP1 and HSF1 expressions. Toxicol. in Vitro 2016, 31, 158-166.
63. Kim, B.J.; Nah, S.Y.; Jeon, J.H.; So, I.; Kim, S.J. Transient receptor potential melastatin 7 channels are involved in ginsenoside Rg3-induced apoptosis in gastric cancer cells. Basic Clin. Pharmacol. Toxicol. 2011, 109, 233-239.
64. Tian, L.; Shen, D.; Li, X.; Shan, X.; Wang, X.; Yan, Q.; Liu, J. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4. Oncotarget 2016, 7, 1619-1632.
65. Guo, J.Q.; Zheng, Q.H.; Chen, H.; Chen, L.; Xu, J.B.; Chen, M.Y.; Lu, D.; Wang, Z.H.; Tong, H.F.; Lin, S. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of vecadherin/EPHA2/MMP9/MMP2 expression. Int. J. Oncol. 2014, 45, 1065-1072.
66. Xu, T.M.; Cui, M.H.; Xin, Y.; Gu, L.P.; Jiang, X.; Su, M.M.; Wang, D.D.; Wang, W.J. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis. Chin. Med. J. 2008, 121, 1394-1397.
67. Kim, J.W.; Jung, S.Y.; Kwon, Y.H.; Lee, S.H.; Lee, J.H.; Lee, B.Y.; Kwon, S.M. Ginsenoside Rg3 inhibits endothelial progenitor cell differentiation through attenuation of VEGF-dependent AKT/ENOS signaling. Phytother. Res. 2012, 26, 1286-1293.
68. Kim, J.W.; Jung, S.Y.; Kwon, Y.H.; Lee, J.H.; Lee, Y.M.; Lee, B.Y.; Kwon, S.M. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells. Cancer Biol. Ther. 2012, 13, 504-515.
69. Son, K.J.; Choi, K.R.; Lee, S.J.; Lee, H. Immunogenic cell death induced by ginsenoside Rg3: Significance in dendritic cell-based anti-Tumor immunotherapy. Immune Netw. 2016, 16, 75-84.
70. Kitts, D.D.; Popovich, D.G.; Hu, C. Characterizing the mechanism for ginsenoside-induced cytotoxicity in cultured leukemia (THP-1) cells. Can. J. Physiol. Pharmacol. 2007, 85, 1173-1183.
71. Huang, J.; Peng, K.; Wang, L.; Wen, B.; Zhou, L.; Luo, T.; Su, M.; Li, J.; Luo, Z. Ginsenoside Rh2 inhibits proliferation and induces apoptosis in human leukemia cells via TNF-signaling pathway. Acta Biochim. Biophys. Sin. 2016.
72. Cheng, C.C.; Yang, S.M.; Huang, C.Y.; Chen, J.C.; Chang, W.M.; Hsu, S.L. Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother. Pharmacol. 2005, 55, 531-540.
73. Li, B.; Zhao, J.;Wang, C.Z.; Searle, J.; He, T.C.; Yuan, C.S.; Du, W. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett. 2011, 301, 185-192.
74. Choi, S.; Oh, J.Y.; Kim, S.J. Ginsenoside Rh2 induces Bcl-2 family proteins-mediated apoptosis in vitro and in xenografts in vivo models. J. Cell. Biochem. 2011, 112, 330-340.
75. Choi, S.; Kim, T.W.; Singh, S.V. Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 INK4B and p27 KIP1-dependent inhibition of cyclin-dependent kinases. Pharm. Res. 2009, 26, 2280-2288.
76. Kikuchi, Y.; Sasa, H.; Kita, T.; Hirata, J.; Tode, T.; Nagata, I. Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo. Anti-Cancer Drugs 1991, 2, 63-67.
77. Musende, A.G.; Eberding, A.;Wood, C.; Adomat, H.; Fazli, L.; Hurtado-Coll, A.; Jia, W.; Bally, M.B.; Guns, E.T. Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: Formulation, pharmacokinetics, biodistribution and efficacy. Cancer Chemother. Pharmacol. 2009, 64, 1085-1095.
78. Xie, X.; Eberding, A.; Madera, C.; Fazli, L.; Jia, W.; Goldenberg, L.; Gleave, M.; Guns, E.S. Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models. J. Urol. 2006, 175, 1926-1931.
79. Kim, Y.S.; Jin, S.H. Ginsenoside Rh2 induces apoptosis via activation of caspase-1 and-3 and up-regulation of bax in human neuroblastoma. Arch. Pharm. Res. 2004, 27, 834-839.
80. Kim, S.Y.; Kim, D.H.; Han, S.J.; Hyun, J.W.; Kim, H.S. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells. Biochem. Pharmacol. 2007, 74, 1642-1651.
81. Fei, X.F.; Wang, B.X.; Tashiro, S.; Li, T.J.; Ma, J.S.; Ikejima, T. Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells. Acta Pharmacol. Sin. 2002, 23, 315-322.
82. Park, E.K.; Lee, E.J.; Lee, S.H.; Koo, K.H.; Sung, J.Y.; Hwang, E.H.; Park, J.H.; Kim, C.W.; Jeong, K.C.; Park, B.K.; et al. Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of AKT. Br. J. Pharmacol. 2010, 160, 1212-1223.
83. Liu, S.; Chen, M.; Li, P.;Wu, Y.; Chang, C.; Qiu, Y.; Cao, L.; Liu, Z.; Jia, C. Ginsenoside Rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma. Cell. Physiol. Biochem. 2015, 36, 499-508.
84. Wang, Z.; Zheng, Q.; Liu, K.; Li, G.; Zheng, R. Ginsenoside Rh2 enhances antitumour activity and decreases genotoxic effect of cyclophosphamide. Basic Clin. Pharmacol. Toxicol. 2006, 98, 411-415.
85. Musende, A.G.; Eberding, A.; Jia, W.; Ramsay, E.; Bally, M.B.; Guns, E.T. Rh2 or its aglycone appd in combination with docetaxel for treatment of prostate cancer. Prostate 2010, 70, 1437-1447.
86. Liu, Z.H.; Li, J.; Xia, J.; Jiang, R.; Zuo, G.W.; Li, X.P.; Chen, Y.; Xiong, W.; Chen, D.L. Ginsenoside 20(S)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells. Chem. Biol. Interact. 2015, 242, 227-234.
87. Lv, Q.; Rong, N.; Liu, L.J.; Xu, X.L.; Liu, J.T.; Jin, F.X.; Wang, C.M. Antitumoral activity of (20R)-And (20S)-ginsenoside Rh2 on transplanted hepatocellular carcinoma in mice. Planta Med. 2016, 82, 705-711.
88. Zhang, Q.; Hong, B.;Wu, S.; Niu, T. Inhibition of prostatic cancer growth by ginsenoside Rh2. Tumour Biol. 2015, 36, 2377-2381.
89. Li, S.; Gao, Y.; Ma, W.; Guo, W.; Zhou, G.; Cheng, T.; Liu, Y. EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumour Biol. 2014, 35, 5593-5598.
90. Yang, Z.; Zhao, T.; Liu, H.; Zhang, L. Ginsenoside Rh2 inhibits hepatocellular carcinoma through-catenin and autophagy. Sci. Rep. 2016, 6, 19383.
91. Zhang, J.; Zhou, F.;Wu, X.; Gu, Y.; Ai, H.; Zheng, Y.; Li, Y.; Zhang, X.; Hao, G.; Sun, J.; et al. 20(S)-ginsenoside Rh2 noncompetitively inhibits p-glycoprotein in vitro and in vivo: A case for herb-drug interactions. Drug Metab. Dispos. 2010, 38, 2179-2187.
92. Zhou, B.; Xiao, X.; Xu, L.; Zhu, L.; Tan, L.; Tang, H.; Zhang, Y.; Xie, Q.; Yao, S. A dynamic study on reversal of multidrug resistance by ginsenoside Rh2 in adriamycin-resistant human breast cancer MCF-7 cells. Talanta 2012, 88, 345-351.
93. Zhang, J.; Zhou, F.; Wu, X.; Zhang, X.; Chen, Y.; Zha, B.S.; Niu, F.; Lu, M.; Hao, G.; Sun, Y.; et al. Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/ADR cells. Br. J. Pharmacol. 2012, 165, 120-134.
94. Shi, Q.; Li, J.; Feng, Z.; Zhao, L.; Luo, L.; You, Z.; Li, D.; Xia, J.; Zuo, G.; Chen, D. Effect of ginsenoside Rh2 on the migratory ability of HEPG2 liver carcinoma cells: Recruiting histone deacetylase and inhibiting activator protein 1 transcription factors. Mol. Med. Rep. 2014, 10, 1779-1785.
95. Dong, H.; Bai, L.P.;Wong, V.K.; Zhou, H.;Wang, J.R.; Liu, Y.; Jiang, Z.H.; Liu, L. The in vitro structure-related anti-cancer activity of ginsenosides and their derivatives. Molecules 2011, 16, 10619-10630.
96. Yoon, J.H.; Choi, Y.J.; Lee, S.G. Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-Activated protein kinase signaling pathway in human hepatocellular carcinoma cells. Eur. J. Pharmacol. 2012, 679, 24-33.
97. Ha, S.E.; Shin, D.H.; Kim, H.D.; Shim, S.M.; Kim, H.S.; Kim, B.H.; Lee, J.S.; Park, J.K. Effects of ginsenoside Rg2 on the ultraviolet B-induced DNA damage responses in hacat cells. Naunyn Schmiedebergs Arch. Pharmacol. 2010, 382, 89-101.
98. Yu, M.; Yu, X.; Guo, D.; Yu, B.; Li, L.; Liao, Q.; Xing, R. Ginsenoside Rg1 attenuates invasion and migration by inhibiting transforming growth factor-induced epithelial to mesenchymal transition in HepG2 cells. Mol. Med. Rep. 2015, 11, 3167-3173.
99. Li, L.;Wang, Y.; Qi, B.; Yuan, D.; Dong, S.; Guo, D.; Zhang, C.; Yu, M. Suppression of PMA-induced tumor cell invasion and migration by ginsenoside Rg1 via the inhibition of NF-B-dependent MMP-9 expression. Oncol. Rep. 2014, 32, 1779-1786.
100. Li, J.; Wei, Q.; Zuo, G.W.; Xia, J.; You, Z.M.; Li, C.L.; Chen, D.L. Ginsenoside Rg1 induces apoptosis through inhibition of the EPOR-mediated JAK2/STAT5 signalling pathway in the TF-1/EPO human leukemia cell line. Asian Pac. J. Cancer Prev. 2014, 15, 2453-2459.
101. Bermejo Benito, P.; Abad Martinez, M.J.; Silvan Sen, A.M.; Sanz Gomez, A.; Fernandez Matellano, L.; Sanchez Contreras, S.; Diaz Lanza, A.M. In vivo and in vitro antiinflammatory activity of saikosaponins. Life Sci. 1998, 63, 1147-1156.
102. Chiang, L.C.; Ng, L.T.; Liu, L.T.; Shieh, D.E.; Lin, C.C. Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species. Planta Medica 2003, 69, 705-709.
103. Cheng, P.W.; Ng, L.T.; Chiang, L.C.; Lin, C.C. Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin. Exp. Pharmacol. Physiol. 2006, 33, 612-616.
104. Wang, R.; Kong, J.;Wang, D.; Lien, L.L.; Lien, E.J. A survey of chinese herbal ingredients with liver protection activities. Chin. Med. 2007, 2.
105. Chen, S.M.; Sato, N.; Yoshida, M.; Satoh, N.; Ueda, S. Effects of bupleurum scorzoneraefolium, bupleurum falcatum, and saponins on nephrotoxic serum nephritis in mice. J. Ethnopharmacol. 2008, 116, 397-402.
106. Yano, H.; Mizoguchi, A.; Fukuda, K.; Haramaki, M.; Ogasawara, S.; Momosaki, S.; Kojiro, M. The herbal medicine SHO-SAIKO-TO inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res. 1994, 54, 448-454.
107. Kao, S.T.; Yeh, C.C.; Hsieh, C.C.; Yang, M.D.; Lee, M.R.; Liu, H.S.; Lin, J.G. The chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest. Life Sci. 2001, 69, 1485-1496.
108. Tatsuta, M.; Iishi, H.; Baba, M.; Nakaizumi, A.; Uehara, H. Inhibition by Xiao-Chai-Hu-Tang (TJ-9) of development of hepatic FOCI induced by n-nitrosomorpholine in sprague-dawley rats. Jpn. J. Cancer Res. 1991, 82, 987-992.
109. Shyu, K.G.; Tsai, S.C.; Wang, B.W.; Liu, Y.C.; Lee, C.C. Saikosaponin c induces endothelial cells growth, migration and capillary tube formation. Life Sci. 2004, 76, 813-826.
110. Zong, Z.; Fujikawa-Yamamoto, K.; Tanino, M.; Teraoka, K.; Yamagishi, H.; Odashima, S. Saikosaponin B2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity. Biochem. Biophys. Res. Commun. 1996, 219, 480-485.
111. Li, D.Q.; Wu, J.; Liu, L.Y.; Wu, Y.Y.; Li, L.Z.; Huang, X.X.; Liu, Q.B.; Yang, J.Y.; Song, S.J.;Wu, C.F. Cytotoxic triterpenoid glycosides (saikosaponins) from the roots of Bupleurum chinense. Bioorg. Med. Chem. Lett. 2015, 25, 3887-3892.
112. Lee, K.J.; Xu, M.Y.; Shehzad, O.; Seo, E.K.; Kim, Y.S. Separation of triterpenoid saponins from the root of Bupleurum falcatum by counter current chromatography: The relationship between the partition coefficients and solvent system composition. J. Sep. Sci. 2014, 37, 3587-3594.
113. Wu, W.S.; Hsu, H.Y. Involvement of p-15INK4b and p-16INK4a gene expression in saikosaponin a and TPA-induced growth inhibition of HepG2 cells. Biochem. Biophys. Res. Commun. 2001, 285, 183-187.
114. Qian, L.; Murakami, T.; Kimura, Y.; Takahashi, M.; Okita, K. Saikosaponin a-induced cell death of a human hepatoma cell line (HUH-7): The significance of the sub-G1 peak in a DNA histogram. Pathol. Int. 1995, 45, 207-214.
115. Chen, J.C.; Chang, N.W.; Chung, J.G.; Chen, K.C. Saikosaponin-A induces apoptotic mechanism in human breast MDA-MB-231 and MCF-7 cancer cells. Am. J. Chin. Med. 2003, 31, 363-377.
116. Tsai, Y.J.; Chen, I.L.; Horng, L.Y.;Wu, R.T. Induction of differentiation in rat c6 glioma cells with saikosaponins. Phytother. Res. 2002, 16, 117-121.
117. Kim, B.M.; Hong, S.H. Sequential caspase-2 and caspase-8 activation is essential for saikosaponin a-induced apoptosis of human colon carcinoma cell lines. Apoptosis 2011, 16, 184-197.
118. Ye, R.P.; Chen, Z.D. Saikosaponin A, an active glycoside from Radix bupleuri, reverses P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cells and HepG2/adm cells. Xenobiotica 2016, 1-9.
119. Hsu, Y.L.; Kuo, P.L.; Lin, C.C. The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells. Life Sci. 2004, 75, 1231-1242.
120. Motoo, Y.; Sawabu, N. Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines. Cancer Lett. 1994, 86, 91-95.
121. Hsu, Y.L.; Kuo, P.L.; Chiang, L.C.; Lin, C.C. Involvement of p53, nuclear factor kappab and FAS/FAS ligand in induction of apoptosis and cell cycle arrest by saikosaponin D in human hepatoma cell lines. Cancer Lett. 2004, 213, 213-221.
122. Jia, X.; Dang, S.; Cheng, Y.; Zhang, X.; Li, M.; Li, Y.; Li, S. Effects of saikosaponin-d on syndecan-2, matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in ratswith hepatocellular carcinoma. J. Tradit. Chin. Med. 2012, 32, 415-422.
123. Yao, M.; Yang, J.; Cao, L.; Zhang, L.; Qu, S.; Gao, H. Saikosaponind inhibits proliferation of DU145 human prostate cancer cells by inducing apoptosis and arresting the cell cycle at G0/G1 phase. Mol. Med. Rep. 2014, 10, 365-372.
124. Liu, R.Y.; Li, J.P. Saikosaponin-d inhibits proliferation of human undifferentiated thyroid carcinoma cells through induction of apoptosis and cell cycle arrest. Eur. Rev. Med. Pharmacol. Sci. 2014, 18, 2435-2443.
125. Wang, B.F.; Wang, X.J.; Kang, H.F.; Bai, M.H.; Guan, H.T.; Wang, Z.W.; Zan, Y.; Song, L.Q.; Min, W.L.; Lin, S.; et al. Saikosaponin-d enhances radiosensitivity of hepatoma cells under hypoxic conditions by inhibiting hypoxia-inducible factor-1. Cell. Physiol. Biochem. 2014, 33, 37-51.
126. Lu, X.L.; He, S.X.; Ren, M.D.;Wang, Y.L.; Zhang, Y.X.; Liu, E.Q. Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: Involvement of CCAAT/enhancer binding protein beta and cyclooxygenase-2. Mol. Med. Rep. 2012, 5, 637-644.
127. He, S.; Lu, G.; Hou, H.; Zhao, Z.; Zhu, Z.; Lu, X.; Chen, J.; Wang, Z. Saikosaponind suppresses the expression of cyclooxygenase2 through the phosphosignal transducer and activator of transcription 3/hypoxiainducible factor1alpha pathway in hepatocellular carcinoma cells. Mol. Med. Rep. 2014, 10, 2556-2562.
128. Wang, B.F.; Lin, S.; Bai, M.H.; Song, L.Q.; Min, W.L.; Wang, M.; Yang, P.; Ma, H.B.; Wang, X.J. Effects of SSD combined with radiation on inhibiting SMMC-7721 hepatoma cell growth. Med. Sci. Monit. 2014, 20, 1340-1344.
129. Wong, V.K.; Li, T.; Law, B.Y.; Ma, E.D.; Yip, N.C.; Michelangeli, F.; Law, C.K.; Zhang, M.M.; Lam, K.Y.; Chan, P.L.; et al. Saikosaponin-d, a novel serca inhibitor, induces autophagic cell death in apoptosis-defective cells. Cell Death Dis. 2013, 4.
130. Zhong, D.; Zhang, H.J.; Jiang, Y.D.; Wu, P.; Qi, H.; Cai, C.; Zheng, S.B.; Dang, Q. Saikosaponin-d: A potential chemotherapeutics in castration resistant prostate cancer by suppressing cancer metastases and cancer stem cell phenotypes. Biochem. Biophys. Res. Commun. 2016, 474, 722-729.
131. Lu, B.; Xu, Y.; Xu, L.; Cong, X.; Yin, L.; Li, H.; Peng, J. Mechanism investigation of dioscin against CCl4-induced acute liver damage in mice. Environ. Toxicol. Pharmacol. 2012, 34, 127-135.
132. Tao, X.; Sun, X.; Yin, L.; Han, X.; Xu, L.; Qi, Y.; Xu, Y.; Li, H.; Lin, Y.; Liu, K.; et al. Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via hmgb-1 inhibition. Free Radic. Biol. Med. 2015, 84, 103-115.
133. Wu, S.; Xu, H.; Peng, J.;Wang, C.; Jin, Y.; Liu, K.; Sun, H.; Qin, J. Potent anti-inflammatory effect of dioscin mediated by suppression of TNF-induced vcam-1, icam-1and el expression via the NF-B pathway. Biochimie 2015, 110, 62-72.
134. Liu, M.J.;Wang, Z.; Ju, Y.; Zhou, J.B.;Wang, Y.;Wong, R.N. The mitotic-Arresting and apoptosis-inducing effects of diosgenyl saponins on human leukemia cell lines. Biol. Pharm. Bull. 2004, 27, 1059-1065.
135. Wang, Z.; Zhou, J.; Ju, Y.; Zhang, H.; Liu, M.; Li, X. Effects of two saponins extracted from the Polygonatum Zanlanscianense pamp on the human leukemia (HL-60) cells. Biol. Pharm. Bull. 2001, 24, 159-162.
136. Hsieh, M.J.; Tsai, T.L.; Hsieh, Y.S.;Wang, C.J.; Chiou, H.L. Dioscin-induced autophagy mitigates cell apoptosis through modulation of PI3K/AKT and ERK and JNK signaling pathways in human lung cancer cell lines. Arch. Toxicol. 2013, 87, 1927-1937.
137. Wei, Y.; Xu, Y.; Han, X.; Qi, Y.; Xu, L.; Xu, Y.; Yin, L.; Sun, H.; Liu, K.; Peng, J. Anti-cancer effects of dioscin on three kinds of human lung cancer cell lines through inducing DNA damage and activating mitochondrial signal pathway. Food Chem. Toxicol. 2013, 59, 118-128.
138. He, X.; Qiao, A.;Wang, X.; Liu, B.; Jiang, M.; Su, L.; Yao, X. Structural identification of methyl protodioscin metabolites in rats' urine and their antiproliferative activities against human tumor cell lines. Steroids 2006, 71, 828-833.
139. Wang, Z.; Cheng, Y.;Wang, N.;Wang, D.M.; Li, Y.W.; Han, F.; Shen, J.G.; Yang de, P.; Guan, X.Y.; Chen, J.P. Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins. Cancer Biol. Ther. 2012, 13, 138-147.
140. Hsieh, M.J.; Yang, S.F.; Hsieh, Y.S.; Chen, T.Y.; Chiou, H.L. Autophagy inhibition enhances apoptosis induced by dioscin in HUH7 cells. Evid.-Based Complement. Altern. Med. 2012, 2012, 134512.
141. Gao, L.L.; Li, F.R.; Jiao, P.; Yang, M.F.; Zhou, X.J.; Si, Y.H.; Jiang, W.J.; Zheng, T.T. Paris chinensis dioscin induces G2/M cell cycle arrest and apoptosis in human gastric cancer SGC-7901 cells. World J. Gastroenterol. 2011, 17, 4389-4395.
142. Hu, M.; Xu, L.; Yin, L.; Qi, Y.; Li, H.; Xu, Y.; Han, X.; Peng, J.;Wan, X. Cytotoxicity of dioscin in human gastric carcinoma cells through death receptor and mitochondrial pathways. J. Appl. Toxicol. 2013, 33, 712-722.
143. Chen, H.; Xu, L.; Yin, L.; Xu, Y.; Han, X.; Qi, Y.; Zhao, Y.; Liu, K.; Peng, J. ITRAQ-based proteomic analysis of dioscin on human HCT-116 colon cancer cells. Proteomics 2014, 14, 51-73.
144. Cai, J.; Liu, M.; Wang, Z.; Ju, Y. Apoptosis induced by dioscin in hela cells. Biol. Pharm. Bull. 2002, 25, 193-196.
145. Gao, L.L.; Li, F.R.; Jiao, P.; Yao, S.T.; Sang, H.; Si, Y.H. Apoptosis of human ovarian cancer cells induced by paris chinensis dioscin via a Ca2+-mediated mitochondrion pathway. Asian Pac. J. Cancer Prev. 2011, 12, 1361-1366.
146. Chen, J.; Li, H.M.; Zhang, X.N.; Xiong, C.M.; Ruan, J.L. Dioscin-induced apoptosis of human lncap prostate carcinoma cells through activation of caspase-3 and modulation of Bcl-2 protein family. J. Huazhong Univ. Sci. Technol. Med. Sci. 2014, 34, 125-130.
147. Kim, E.A.; Jang, J.H.; Lee, Y.H.; Sung, E.G.; Song, I.H.; Kim, J.Y.; Kim, S.; Sohn, H.Y.; Lee, T.J. Dioscin induces caspase-independent apoptosis through activation of apoptosis-inducing factor in breast cancer cells. Apoptosis 2014, 19, 1165-1175.
148. Tong, Q.; Qing, Y.; Wu, Y.; Hu, X.; Jiang, L.; Wu, X. Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways. Toxicol. Appl. Pharmacol. 2014, 281, 166-173.
149. Shuli, M.; Wenyuan, G.; Yanjun, Z.; Chaoyi, M.; Liu, Y.; Yiwen, L. Paridis saponins inhibiting carcinoma growth and metastasis in vitro and in vivo. Arch. Pharm. Res. 2011, 34, 43-50.
150. Xu, T.; Zhang, S.; Zheng, L.; Yin, L.; Xu, L.; Peng, J. A 90-day subchronic toxicological assessment of dioscin, a natural steroid saponin, in sprague-dawley rats. Food Chem. Toxicol. 2012, 50, 1279-1287.
151. Lv, L.; Zheng, L.; Dong, D.; Xu, L.; Yin, L.; Xu, Y.; Qi, Y.; Han, X.; Peng, J. Dioscin, a natural steroid saponin, induces apoptosis and DNA damage through reactive oxygen species: A potential new drug for treatment of glioblastoma multiforme. Food Chem. Toxicol. 2013, 59, 657-669.
152. Wang, Y.; He, Q.Y.; Chiu, J.F. Dioscin induced activation of p38 MAPK and JNK via mitochondrial pathway in HL-60 cell line. Eur. J. Pharmacol. 2014, 735, 52-58.
153. Wang, Y.; Cheung, Y.H.; Yang, Z.; Chiu, J.F.; Che, C.M.; He, Q.Y. Proteomic approach to study the cytotoxicity of dioscin (saponin). Proteomics 2006, 6, 2422-2432.
154. Si, L.; Zheng, L.; Xu, L.; Yin, L.; Han, X.; Qi, Y.; Xu, Y.;Wang, C.; Peng, J. Dioscin suppresses human laryngeal cancer cells growth via induction of cell-cycle arrest and mapk-mediated mitochondrial-derived apoptosis and inhibition of tumor invasion. Eur. J. Pharmacol. 2016, 774, 105-117.
155. Kim, Y.S.; Kim, E.A.; Park, K.G.; Lee, S.J.; Kim, M.S.; Sohn, H.Y.; Lee, T.J. Dioscin sensitizes cells to trail-induced apoptosis through downregulation of c-FLIP and Bcl-2. Oncol. Rep. 2012, 28, 1910-1916.
156. Zhao, X.; Tao, X.; Xu, L.; Yin, L.; Qi, Y.; Xu, Y.; Han, X.; Peng, J. Dioscin induces apoptosis in human cervical carcinoma hela and siha cells through ROS-mediated DNA damage and the mitochondrial signaling pathway. Molecules 2016, 21.
157. Ivanova, A.; Serly, J.; Dinchev, D.; Ocsovszki, I.; Kostova, I.; Molnar, J. Screening of some saponins and phenolic components of tribulus terrestris and smilax excelsa as mdr modulators. In Vivo 2009, 23, 545-550.
158. Sun, B.T.; Zheng, L.H.; Bao, Y.L.; Yu, C.L.; Wu, Y.; Meng, X.Y.; Li, Y.X. Reversal effect of dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells. Eur. J. Pharmacol. 2011, 654, 129-134.
159. Wang, L.; Meng, Q.; Wang, C.; Liu, Q.; Peng, J.; Huo, X.; Sun, H.; Ma, X.; Liu, K. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia k562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-B signaling inhibition. J. Natl. Prod. 2013, 76, 909-914.
160. Li, W.; Qiu, Z.; Wang, Y.; Zhang, Y.; Li, M.; Yu, J.; Zhang, L.; Zhu, Z.; Yu, B. Synthesis, cytotoxicity, and hemolytic activity of 60-O-substituted dioscin derivatives. Carbohydr. Res. 2007, 342, 2705-2715.
161. Aumsuwan, P.; Khan, S.I.; Khan, I.A.; Ali, Z.; Avula, B.; Walker, L.A.; Shariat-Madar, Z.; Helferich, W.G.; Katzenellenbogen, B.S.; Dasmahapatra, A.K. The anticancer potential of steroidal saponin, dioscin, isolated from wild yam (Dioscorea villosa) root extract in invasive human breast cancer cell line MDA-MB-231 in vitro. Arch. Biochem. Biophys. 2016, 591, 98-110.
162. Yang, C.; Cai, H.; Meng, X. Polyphyllin D induces apoptosis and differentiation in K562 human leukemia cells. Int. Immunopharmacol. 2016, 36, 17-22.
163. Wu, L.; Li, Q.; Liu, Y. Polyphyllin D induces apoptosis in K562/A02 cells through G2/M phase arrest. J. Pharm. Pharmacol. 2014, 66, 713-721.
164. Lee, M.S.; Yuet-Wa, J.C.; Kong, S.K.; Yu, B.; Eng-Choon, V.O.; Nai-Ching, H.W.; Chung-Wai, T.M.; Fung, K.P. Effects of polyphyllin D, a steroidal saponin in Paris polyphylla, in growth inhibition of human breast cancer cells and in xenograft. Cancer Biol. Ther. 2005, 4, 1248-1254.
165. Siu, F.M.; Ma, D.L.; Cheung, Y.W.; Lok, C.N.; Yan, K.; Yang, Z.; Yang, M.; Xu, S.; Ko, B.C.; He, Q.Y.; et al. Proteomic and transcriptomic study on the action of a cytotoxic saponin (polyphyllin D): Induction of endoplasmic reticulum stress and mitochondria-mediated apoptotic pathways. Proteomics 2008, 8, 3105-3117.
166. Cheung, J.Y.; Ong, R.C.; Suen, Y.K.; Ooi, V.; Wong, H.N.; Mak, T.C.; Fung, K.P.; Yu, B.; Kong, S.K. Polyphyllin D is a potent apoptosis inducer in drug-resistant HepG2 cells. Cancer Lett. 2005, 217, 203-211.
167. Yu, Q.; Li, Q.; Lu, P.; Chen, Q. Polyphyllin D induces apoptosis in U87 human glioma cells through the c-Jun NH2-Terminal kinase pathway. J. Med. Food 2014, 17, 1036-1042.
168. Nguyen, V.T.; Darbour, N.; Bayet, C.; Doreau, A.; Raad, I.; Phung, B.H.; Dumontet, C.; Di Pietro, A.; Dijoux-Franca, M.G.; Guilet, D. Selective modulation of P-glycoprotein activity by steroidal saponines from Paris polyphylla. Fitoterapia 2009, 80, 39-42.
169. Al Sawah, E.; Marchion, D.C.; Xiong, Y.; Ramirez, I.J.; Abbasi, F.; Boac, B.M.; Bush, S.H.; Bou Zgheib, N.; McClung, E.C.; Khulpateea, B.R.; et al. The chinese herb polyphyllin D sensitizes ovarian cancer cells to cisplatin-induced growth arrest. J. Cancer Res. Clin. Oncol. 2015, 141, 237-242.
170. Ong, R.C.; Lei, J.; Lee, R.K.; Cheung, J.Y.; Fung, K.P.; Lin, C.; Ho, H.P.; Yu, B.; Li, M.; Kong, S.K. Polyphyllin D induces mitochondrial fragmentation and acts directly on the mitochondria to induce apoptosis in drug-resistant HepG2 cells. Cancer Lett. 2008, 261, 158-164.
171. Ma, D.D.; Lu, H.X.; Xu, L.S.; Xiao, W. Polyphyllin D exerts potent anti-Tumour effects on lewis cancer cells under hypoxic conditions. J. Int. Med. Res. 2009, 37, 631-640.
172. Chan, J.Y.; Koon, J.C.; Liu, X.; Detmar, M.; Yu, B.; Kong, S.K.; Fung, K.P. Polyphyllin D, a steroidal saponin from Paris polyphylla, inhibits endothelial cell functions in vitro and angiogenesis in zebrafish embryos in vivo. J. Ethnopharmacol. 2011, 137, 64-69.
173. Liu, M.; Tao, L.; Chau, S.L.; Wu, R.; Zhang, H.; Yang, Y.; Yang, D.; Bian, Z.; Lu, A.; Han, Q.; et al. Folding fan mode counter-current chromatography offers fast blind screening for drug discovery. Case study: Finding anti-enterovirus 71 agents from Anemarrhena asphodeloides. J. Chromatogr. A 2014, 1368, 116-124.
174. Kang, L.P.; Zhang, J.; Cong, Y.; Li, B.; Xiong, C.Q.; Zhao, Y.; Tan, D.W.; Yu, H.S.; Yu, Z.Y.; Cong, Y.W.; et al. Steroidal glycosides from the rhizomes of Anemarrhena asphodeloides and their antiplatelet aggregation activity. Planta Medica 2012, 78, 611-616.
175. Lu, W.Q.; Qiu, Y.; Li, T.J.; Tao, X.; Sun, L.N.; Chen, W.S. Antiplatelet and antithrombotic activities of timosaponin B-II, an extract of Anemarrhena asphodeloides. Clin. Exp. Pharmacol. Physiol. 2011, 38, 430-434.
176. Wang, G.J.; Lin, L.C.; Chen, C.F.; Cheng, J.S.; Lo, Y.K.; Chou, K.J.; Lee, K.C.; Liu, C.P.;Wu, Y.Y.; Su, W.; et al. Effect of timosaponin A-III, from Anemarrhenae asphodeloides Bunge (Liliaceae), on calcium mobilization in vascular endothelial and smooth muscle cells and on vascular tension. Life Sci. 2002, 71, 1081-1090.
177. Chen, J.R.; Jia, X.H.; Wang, H.; Yi, Y.J.; Wang, J.Y.; Li, Y.J. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/AKT signaling pathway. Int. J. Oncol. 2016, 48, 2063-2070.
178. Zhang, T.; Wang, J.; Wang, S.; Ma, C. Timosaponin B-II inhibits lipopolysaccharide-induced acute lung toxicity via TLR/NF-B pathway. Toxicol. Mech. Methods 2015, 25, 665-671.
179. Li, T.J.; Qiu, Y.; Yang, P.Y.; Rui, Y.C.; Chen, W.S. Timosaponin B-II improves memory and learning dysfunction induced by cerebral ischemia in rats. Neurosci. Lett. 2007, 421, 147-151.
180. King, F.W.; Fong, S.; Griffin, C.; Shoemaker, M.; Staub, R.; Zhang, Y.L.; Cohen, I.; Shtivelman, E. Timosaponin A-III is preferentially cytotoxic to tumor cells through inhibition of mtor and induction of er stress. PLoS ONE 2009, 4, e7283.
181. Kang, Y.J.; Chung, H.J.; Nam, J.W.; Park, H.J.; Seo, E.K.; Kim, Y.S.; Lee, D.; Lee, S.K. Cytotoxic and antineoplastic activity of timosaponin A-III for human colon cancer cells. J. Natl. Prod. 2011, 74, 701-706.
182. Yin, Y.; Zhao, X.C.;Wang, S.J.; Gao, P.Y.; Li, L.Z.; Ikejima, T.; Song, S.J. Synthesis and biological evaluation of novel sarsasapogenin derivatives as potential anti-Tumor agents. Steroids 2015, 93, 25-31.
183. Lok, C.N.; Sy, L.K.; Liu, F.; Che, C.M. Activation of autophagy of aggregation-prone ubiquitinated proteins by timosaponin A-III. J. Biol. Chem. 2011, 286, 31684-31696.
184. Huang, H.L.; Chiang, W.L.; Hsiao, P.C.; Chien, M.H.; Chen, H.Y.; Weng, W.C.; Hsieh, M.J.; Yang, S.F. Timosaponin aiii mediates caspase activation and induces apoptosis through JNK1/2 pathway in human promyelocytic leukemia cells. Tumour Biol. 2015, 36, 3489-3497.
185. Sy, L.K.; Yan, S.C.; Lok, C.N.; Man, R.Y.; Che, C.M. Timosaponin A-III induces autophagy preceding mitochondria-mediated apoptosis in hela cancer cells. Cancer Res. 2008, 68, 10229-10237.
186. Tsai, C.H.; Yang, C.W.; Wang, J.Y.; Tsai, Y.F.; Tseng, L.M.; King, K.L.; Chen, W.S.; Chiu, J.H.; Shyr, Y.M. Timosaponin AIII suppresses hepatocyte growth factor-induced invasive activity through sustained ERK activation in breast cancer MDA-MB-231 cells. Evid. Based Complement. Altern. Med. 2013, 2013.
187. Kim, K.M.; Im, A.R.; Kim, S.H.; Hyun, J.W.; Chae, S. Timosaponin AIII inhibits melanoma cell migration by suppressing COX-2 and in vivo tumor metastasis. Cancer Sci. 2016, 107, 181-188.
188. Sun, C.; Yu, Y.; Wang, L.; Wu, B.; Xia, L.; Feng, F.; Ling, Z.; Wang, S. Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro. J. Exp. Clin. Cancer Res. 2016, 35, 32.
189. Wong, V.K.; Zhang, M.M.; Zhou, H.; Lam, K.Y.; Chan, P.L.; Law, C.K.; Yue, P.Y.; Liu, L. Saikosaponin-D enhances the anticancer potency of TNF-via overcoming its undesirable response of activating NF-B signalling in cancer cells. Evid.-Based Complement. Altern. Med. 2013, 2013, 745295.
190. Xia, T.;Wang, J.;Wang, Y.;Wang, Y.; Cai, J.;Wang, M.; Chen, Q.; Song, J.; Yu, Z.; Huang, W.; et al. Inhibition of autophagy potentiates anticancer property of 20(S)-ginsenoside Rh2 by promoting mitochondria-dependent apoptosis in human acute lymphoblastic leukaemia cells. Oncotarget 2016.
191. Zhu, C.; Liu, F.; Qian, W.; Zhang, T.; Li, F. Combined effect of sodium selenite and ginsenoside Rh2 on HCT116 human colorectal carcinoma cells. Arch. Iran. Med. 2016, 19, 23-29.
192. Chen, F.; Deng, Z.Y.; Zhang, B.; Xiong, Z.X.; Zheng, S.L.; Tan, C.L.; Hu, J.N. Esterification of ginsenoside Rh2 enhanced its cellular uptake and antitumor activity in human HepG2 cells. J. Agric. Food Chem. 2016, 64, 253-261.
193. Nakata, H.; Kikuchi, Y.; Tode, T.; Hirata, J.; Kita, T.; Ishii, K.; Kudoh, K.; Nagata, I.; Shinomiya, N. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn. J. Cancer Res. 1998, 89, 733-740.
194. Liu, J.; Shimizu, K.; Yu, H.; Zhang, C.; Jin, F.; Kondo, R. Stereospecificity of hydroxyl group at c-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells. Fitoterapia 2010, 81, 902-905.
195. Wang, W.;Wang, H.; Rayburn, E.R.; Zhao, Y.; Hill, D.L.; Zhang, R. 20(S)-25-methoxyl-dammarane-3, 12, 20-Triol, a novel natural product for prostate cancer therapy: Activity in vitro and in vivo and mechanisms of action. Br. J. Cancer 2008, 98, 792-802.
196. Guo, J.; Xu, C.; Xue, R.; Jiang, W.; Wu, B.; Huang, C. Cytotoxic activities of chemical constituents from rhizomes of Anemarrhena asphodeloides and their analogues. Arch. Pharm. Res. 2015, 38, 598-603.
197. Zhang, F.; Li, M.; Wu, X.; Hu, Y.; Cao, Y.; Wang, X.; Xiang, S.; Li, H.; Jiang, L.; Tan, Z.; et al. 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway. Drug Des. Dev. Ther. 2015, 9, 3969-3987.
198. Zhao, X.; Xu, L.; Zheng, L.; Yin, L.; Qi, Y.; Han, X.; Xu, Y.; Peng, J. Potent effects of dioscin against gastric cancer in vitro and in vivo. Phytomedicine 2016, 23, 274-282.
199. Xiao, X.; Zou, J.; Bui-Nguyen, T.M.; Bai, P.; Gao, L.; Liu, J.; Liu, S.; Xiao, J.; Chen, X.; Zhang, X.; et al. Paris saponin ii of rhizoma paridis-A novel inducer of apoptosis in human ovarian cancer cells. Biosci. Trends 2012, 6, 201-211.
200. Zheng, K.; Liao, C.; Li, Y.; Fan, X.; Fan, L.; Xu, H.; Kang, Q.; Zeng, Y.; Wu, X.; Wu, H.; et al. Gypenoside l, isolated from Gynostemma pentaphyllum, induces cytoplasmic vacuolation death in hepatocellular carcinoma cells through reactive-oxygen-species-mediated unfolded protein response. J. Agric. Food Chem. 2016, 64, 1702-1711.
201. Liao, C.; Zheng, K.; Li, Y.; Xu, H.; Kang, Q.; Fan, L.; Hu, X.; Jin, Z.; Zeng, Y.; Kong, X.; et al. Gypenoside l inhibits autophagic flux and induces cell death in human esophageal cancer cells through endoplasm reticulum stress-mediated Ca2+ release. Oncotarget 2016.
202. Chen, M.; Guo, Y.; Zhao, R.; Wang, X.; Jiang, M.; Fu, H.; Zhang, X. Ophiopogonin B induces apoptosis, mitotic catastrophe and autophagy in A549 cells. Int. J. Oncol. 2016, 49, 316-324.
203. Zhang, Z.G.;Wu, L.;Wang, J.L.; Yang, J.D.; Zhang, J.; Zhang, J.; Li, L.H.; Xia, Y.; Yao, L.B.; Qin, H.Z.; et al. Astragaloside iv prevents MPP+-induced SH-SY5Y cell death via the inhibition of bax-mediated pathways and ROS production. Mol. Cell. Biochem. 2012, 364, 209-216.
204. Li, T.; Xu, W.S.; Wu, G.S.; Chen, X.P.; Wang, Y.T.; Lu, J.J. Platycodin D induces apoptosis, and inhibits adhesion, migration and invasion in HepG2 hepatocellular carcinoma cells. Asian Pac. J. Cancer Prev. 2014, 15, 1745-1749.
205. Li, T.; Xu, X.H.; Tang, Z.H.; Wang, Y.F.; Leung, C.H.; Ma, D.L.; Chen, X.P.; Wang, Y.T.; Chen, Y.; Lu, J.J. Platycodin D induces apoptosis and triggers ERK-And JNK-mediated autophagy in human hepatocellular carcinoma Bel-7402 cells. Acta Pharmacol. Sin. 2015, 36, 1503-1513.
206. Li, T.; Tang, Z.H.; Xu, W.S.; Wu, G.S.; Wang, Y.F.; Chang, L.L.; Zhu, H.; Chen, X.P.; Wang, Y.T.; Chen, Y.; et al. Platycodin D triggers autophagy through activation of extracellular signal-regulated kinase in hepatocellular carcinoma HepG2 cells. Eur. J. Pharmacol. 2015, 749, 81-88.
207. Tang, Z.H.; Li, T.; Gao, H.W.; Sun, W.; Chen, X.P.; Wang, Y.T.; Lu, J.J. Platycodin D from Platycodonis radix enhances the anti-proliferative effects of doxorubicin on breast cancer MCF-7 and MDA-MB-231 cells. Chin. Med. 2014, 9.
208. Lu, J.J.; Lu, D.Z.; Chen, Y.F.; Dong, Y.T.; Zhang, J.R.; Li, T.; Tang, Z.H.; Yang, Z. Proteomic analysis of hepatocellular carcinoma HepG2 cells treated with platycodin D. Chin. J. Natl. Med. 2015, 13, 673-679.
209. Lee, Y.J.; Son, Y.M.; Gu, M.J.; Song, K.D.; Park, S.M.; Song, H.J.; Kang, J.S.;Woo, J.S.; Jung, J.H.; Yang, D.C.; et al. Ginsenoside fractions regulate the action of monocytes and their differentiation into dendritic cells. J. Ginseng Res. 2015, 39, 29-37.
210. Yuan, D.; Yuan, Q.; Cui, Q.; Liu, C.; Zhou, Z.; Zhao, H.; Dun, Y.; Wang, T.; Zhang, C. Vaccine adjuvant ginsenoside Rg1 enhances immune responses against hepatitis B surface antigen in mice. Can. J. Physiol. Pharmacol. 2016, 94, 676-681.
211. Wei, Z.;Wang, J.; Shi, M.; Liu, W.; Yang, Z.; Fu, Y. Saikosaponin a inhibits LPS-induced inflammatory response by inducing liver X receptor activation in primary mouse macrophages. Oncotarget 2016.
212. Li, W.; Tian, Y.H.; Liu, Y.; Wang, Z.; Tang, S.; Zhang, J.; Wang, Y.P. Platycodin D exerts anti-Tumor efficacy in H22 tumor-bearing mice via improving immune function and inducing apoptosis. J. Toxicol. Sci. 2016, 41, 417-428.
213. Wisloff, H.; Uhlig, S.; Scheie, E.; Loader, J.;Wilkins, A.; Flaoyen, A. Toxicity testing of saponin-containing Yucca schidigera Roetzl. juice in relation to hepato-And nephrotoxicity of Narthecium ossifragum (L.) Huds. Toxicon 2008, 51, 140-150.
214. Lorent, J.H.; Quetin-Leclercq, J.; Mingeot-Leclercq, M.P. The amphiphilic nature of saponins and their effects on artificial and biological membranes and potential consequences for red blood and cancer cells. Org. Biomol. Chem. 2014, 12, 8803-8822.
215. Yu, K.; Chen, F.; Li, C. Absorption, disposition, and pharmacokinetics of saponins from Chinese medicinal herbs: What do we know and what do we need to know more? Curr. Drug Metab. 2012, 13, 577-598.
216. Gao, S.; Basu, S.; Yang, Z.; Deb, A.; Hu, M. Bioavailability challenges associated with development of saponins as therapeutic and chemopreventive agents. Curr. Drug Targets 2012, 13, 1885-1899.
217. Hao, F.; He, Y.; Sun, Y.; Zheng, B.; Liu, Y.; Wang, X.; Zhang, Y.; Lee, R.J.; Teng, L.; Xie, J. Improvement of oral availability of ginseng fruit saponins by a proliposome delivery system containing sodium deoxycholate. Saudi J. Biol. Sci. 2016, 23, S113-S125.
218. Lee, J.Y.; Yang, H.; Yoon, I.S.; Kim, S.B.; Ko, S.H.; Shim, J.S.; Sung, S.H.; Cho, H.J.; Kim, D.D. Nanocomplexes based on amphiphilic hyaluronic acid derivative and polyethylene glycol-lipid for ginsenoside Rg3 delivery. J. Pharm. Sci. 2014, 103, 3254-3262.